Published in Eur J Gastroenterol Hepatol on October 01, 2006
Mast cells play a crucial role in Staphylococcus aureus peptidoglycan-induced diarrhea. Am J Pathol (2007) 1.06
Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis. Clin Exp Gastroenterol (2008) 1.02
Deoxycholate-induced colitis is markedly attenuated in Nos2 knockout mice in association with modulation of gene expression profiles. Dig Dis Sci (2007) 0.86
Detection of calprotectin and apoptotic activity in the colon of marmosets with chronic diarrhea. J Vet Med Sci (2013) 0.82
New molecular insights into inflammatory bowel disease-induced diarrhea. Expert Rev Gastroenterol Hepatol (2011) 0.81
Treatment of diarrhoea in rural African communities: an overview of measures to maximise the medicinal potentials of indigenous plants. Int J Environ Res Public Health (2012) 0.80
McKittrick-Wheelock syndrome: a rare cause of diarrhoea. Eur J Gastroenterol Hepatol (2006) 1.59
Five-year colon surveillance after screening colonoscopy. Gastroenterology (2007) 3.74
Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol (2004) 2.86
Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol (2004) 2.65
Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. Can J Gastroenterol (2005) 2.36
Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain?: a meta-analysis. Arch Intern Med (2005) 2.35
Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol (2008) 2.28
The use of zoledronic acid in men receiving androgen deprivation therapy for prostate cancer with severe osteopenia or osteoporosis. Urology (2010) 2.14
DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res (2002) 2.13
Carcinogenicity of deoxycholate, a secondary bile acid. Arch Toxicol (2011) 1.92
Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment. Am J Physiol Gastrointest Liver Physiol (2006) 1.83
Effects of gastroesophageal reflux disease on sleep and outcomes. Clin Gastroenterol Hepatol (2009) 1.76
Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. Gastrointest Endosc (2010) 1.69
Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol (2009) 1.63
The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid. Am J Physiol Gastrointest Liver Physiol (2012) 1.60
Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus. Gut (2006) 1.58
Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium. Am J Gastroenterol (2002) 1.56
Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain. J Clin Gastroenterol (2004) 1.52
Irritable bowel syndrome patients show enhanced modulation of visceral perception by auditory stress. Am J Gastroenterol (2003) 1.50
Bladder cancer presenting as lower-GI bleeding. Dig Dis Sci (2008) 1.47
Clinical predictors of Barrett's esophagus length. Gastrointest Endosc (2005) 1.45
Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol (2009) 1.34
Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded. J Neurogastroenterol Motil (2011) 1.32
Burnout in medical students: a systematic review. Clin Teach (2013) 1.30
Field defects in progression to gastrointestinal tract cancers. Cancer Lett (2007) 1.28
The effect of life stress on symptoms of heartburn. Psychosom Med (2004) 1.28
Noncardiac chest pain: evaluation and treatment. Gastroenterol Clin North Am (2003) 1.26
Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database. Am J Gastroenterol (2007) 1.22
Activation of the interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to barrett's esophagus. Clin Cancer Res (2007) 1.21
The diagnosis of gastroesophageal reflux disease. Am J Med (2010) 1.17
Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel. J Am Coll Surg (2013) 1.16
Nicotine increases oxidative stress, activates NF-kappaB and GRP78, induces apoptosis and sensitizes cells to genotoxic/xenobiotic stresses by a multiple stress inducer, deoxycholate: relevance to colon carcinogenesis. Chem Biol Interact (2003) 1.15
Apoptosis resistance in Barrett's esophagus: ex vivo bioassay of live stressed tissues. Am J Gastroenterol (2005) 1.13
Crypt-restricted loss and decreased protein expression of cytochrome C oxidase subunit I as potential hypothesis-driven biomarkers of colon cancer risk. Cancer Epidemiol Biomarkers Prev (2005) 1.12
Laparoscopic resection of a small bowel lipoma with incidental intussusception. JSLS (2011) 1.12
Bile acids induce ileal damage during experimental necrotizing enterocolitis. Gastroenterology (2006) 1.11
Increased expression and secretion of interleukin-6 in patients with Barrett's esophagus. Clin Cancer Res (2004) 1.10
Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology (2007) 1.07
Pharmacological management of GERD: where does it stand now? Trends Pharmacol Sci (2011) 1.06
Epidermal growth factor reduces autophagy in intestinal epithelium and in the rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol (2010) 1.06
Is there a relationship between obstructive sleep apnea and gastroesophageal reflux disease? Clin Gastroenterol Hepatol (2004) 1.05
Adaptive value of sex in microbial pathogens. Infect Genet Evol (2008) 1.04
Nonerosive Reflux Disease (NERD) - An Update. J Neurogastroenterol Motil (2010) 1.04
Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors. Curr Opin Gastroenterol (2010) 1.04
Gastroesophageal reflux disease in noncardiac chest pain. Gastroenterol Clin North Am (2004) 1.04
Relationships between sleep quality and pH monitoring findings in persons with gastroesophageal reflux disease. J Clin Sleep Med (2007) 1.03
Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate. Carcinogenesis (2002) 1.02
Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis. Clin Exp Gastroenterol (2008) 1.02
A novel mechanism of acid and bile acid-induced DNA damage involving Na+/H+ exchanger: implication for Barrett's oesophagus. Gut (2010) 1.00
Deficient expression of DNA repair enzymes in early progression to sporadic colon cancer. Genome Integr (2012) 1.00
Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS)--is it one disease or an overlap of two disorders? Dig Dis Sci (2008) 0.99
A systematic review of the definitions, prevalence, and response to treatment of nocturnal gastroesophageal reflux disease. Clin Gastroenterol Hepatol (2008) 0.99
Intravenous zoledronic acid to prevent osteoporosis in a veteran population with multiple risk factors for bone loss on androgen deprivation therapy. J Urol (2009) 0.99
An algorithm for diagnosis and treatment of refractory GERD. Best Pract Res Clin Gastroenterol (2010) 0.98
Identification of S-nitrosylated proteins after chronic exposure of colon epithelial cells to deoxycholate. Proteomics (2006) 0.98
Role of mitochondrial complexes I and II, reactive oxygen species and arachidonic acid metabolism in deoxycholate-induced apoptosis. Cancer Lett (2002) 0.97
Unique dietary-related mouse model of colitis. Inflamm Bowel Dis (2006) 0.96
Low-dose 3 mg levobupivacaine plus 10 microg fentanyl selective spinal anesthesia for gynecological outpatient laparoscopy. Anesth Analg (2009) 0.96
Responding to the Call for Improving Resident Wellness. Acad Med (2016) 0.95
The pathophysiology of non-cardiac chest pain. J Gastroenterol Hepatol (2005) 0.95
Treatment of patients with diabetic gastroparesis. Gastroenterol Hepatol (N Y) (2010) 0.95
Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid. Am J Gastroenterol (2006) 0.95
Assessment of apoptosis by immunohistochemical markers compared to cellular morphology in ex vivo-stressed colonic mucosa. J Histochem Cytochem (2005) 0.94
The proton pump inhibitor (PPI) test in GERD: does it still have a role? J Clin Gastroenterol (2008) 0.93
Nonmedical therapeutic strategies for nonerosive reflux disease. J Clin Gastroenterol (2014) 0.93
Characterization of squamous esophageal cells resistant to bile acids at acidic pH: implication for Barrett's esophagus pathogenesis. Am J Physiol Gastrointest Liver Physiol (2010) 0.92
Gastroesophageal reflux disease and sleep disturbances. J Gastroenterol (2012) 0.91
Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups. Am J Gastroenterol (2006) 0.91
A proteomic study of resistance to deoxycholate-induced apoptosis. Carcinogenesis (2004) 0.90